P. Rodríguez-Wilhelmi

Tumor necrosis factor-alpha inhibition reduces CXCL-8 levels but fails to prevent fibrin generation and does not improve outcome in a rabbit model of endotoxic shock.

A. Matsukawa, H. Nariuchi, M. Montes, 2003, The Journal of laboratory and clinical medicine.

Interleukin (IL)-8 and growth related oncogene-α in severe endotoxemia and the effects of a tumor necrosis factor-α/IL-1β inhibitor on these chemokines

A. Matsukawa, M. Montes, J. Hermida, 2002 .

Screening for occult malignancy with FDG‐PET/CT in patients with unprovoked venous thromboembolism

J. Paramo, R. Lecumberri, J. Richter, 2013, International journal of cancer.

Interleukin (IL)-8 and growth related oncogene-alpha in severe endotoxemia and the effects of a tumor necrosis factor-alpha/IL-1beta inhibitor on these chemokines.

A. Matsukawa, M. Montes, J. Hermida, 2002, Experimental and molecular pathology.

Long-Term Survival in Primary Plasma Cell Leukemia after Therapy with VAD, Autologous Blood Stem Cell Transplantation and Interferon-Alpha

J. Rifón, P. Rodríguez-Wilhelmi, C. Panizo, 1999, Acta Haematologica.

Identification of six new RHCE variant alleles in individuals of diverse racial origin

F. Garcia-sanchez, C. Hyland, A. Cemborain, 2016, Transfusion.

[Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients].

E. Rocha, E. Ruza, P. Rodríguez-Wilhelmi, 2001, Medicina clinica.

Three new alleles encoding an apparent Kellnull phenotype

F. Garcia-sanchez, G. Ochoa-Garay, P. Rodríguez-Wilhelmi, 2017, Transfusion.